Xanax and Sirolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xanax and Sirolimus. Common interactions include drug toxicity among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people who take Xanax and Sirolimus have. It is created by eHealthMe based on reports of 19 people who take Xanax and Sirolimus from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

19 people who take Xanax and Sirolimus together, and have interactions are studied.

What is Xanax?

Xanax has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 128,154 Xanax users for its effectiveness, alternative drugs and more.

What is Sirolimus?

Sirolimus has active ingredients of sirolimus. eHealthMe is studying from 9,391 Sirolimus users for its effectiveness, alternative drugs and more.

Number of Xanax and Sirolimus reports submitted per year:

Common Xanax and Sirolimus drug interactions by gender *:

female:

Drug toxicity
Acute myocardial infarction
Constipation
Dizziness
Headache
Insomnia
Nausea
Pericardial effusion
Pleural effusion
Renal failure

male:

Pneumonia
Anaemia
Hypertension
Hypoxia
Nausea
Respiratory failure
Abdominal pain upper
Acne
Acute respiratory failure
Affective disorder

Common Xanax and Sirolimus drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain upper
Acne
Acute respiratory failure
Decreased appetite
Depression
Diastolic dysfunction
Epistaxis
Haemoptysis
Haemorrhagic anaemia
Heart transplant rejection

30-39:

Drug toxicity
Dyskinesia
Eye disorder
Hemiplegia
Mental status changes
Urinary incontinence

40-49:

Acute myocardial infarction
Asthenia
Chondrosarcoma
Chronic kidney disease
Constipation
Dizziness
Dyspnoea
Headache
Insomnia
Nausea

50-59:

Blood creatinine increased
Chronic kidney disease
Diarrhoea
Kidney transplant rejection
Renal injury
Renal tubular necrosis

60+:

Malaise
Abdominal discomfort
Fall
Affective disorder
Aortic stenosis
Aphasia
Asbestosis
Asthenia
Back pain
Balance disorder

Common conditions people have *:

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
Sedation: 1 person, 5.26%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 5.26%
Antineutrophil Cytoplasmic Antibody Decreased: 1 person, 5.26%
Asthma: 1 person, 5.26%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 1 person, 5.26%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 5.26%
Depression: 1 person, 5.26%
Drug Hypersensitivity: 1 person, 5.26%
High Blood Cholesterol: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Xanax and Sirolimus?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.